This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Discover antibody-based imaging strategies that help doctors visualize patients’ tumors and immune cells in real-time via PET scans.
Discover the full potential of genome-based medicine with genomic and genetic testing for cancer risk and tumor assessment with Corrie Painter, Ph.D., and Eliezer Van Allen, M.D.
Discover how doctors and patients can recognize and safely manage an overstimulated or misdirected immune response.
Discover the microscopic organisms that inhabit our bodies and new microbiome-based treatment strategies in the clinic.
Dr. Padmanee Sharma of MD Anderson discusses what breakthroughs and advances might lie ahead for the field of cancer immunotherapy in 2020.
Dr. Michel Sadelain of Memorial Sloan Kettering highlights a revolutionary new treatment approach—CAR T cell immunotherapy—that he helped pioneer.
Brendan Connors and his oncologist Dr. Michael Postow of Memorial Sloan Kettering discuss the importance of communication between patient and doctor throughout immunotherapy treatment.
Dr. Patrick Hwu of the MD Anderson highlights the promise and potential of combination immunotherapies and how biomarkers can be used to guide these strategies.
Dr. Elizabeth M. Jaffee of Johns Hopkins University discusses cancer immunotherapy’s ongoing efforts to overcome the challenges ahead and enable immunotherapy to benefit even more people with cancer.
Caregivers Casey Zmudzinski and Benny Juarez, and cancer veteran Kristin Kleinhofer, discuss how they advocate for the best care possible for their loved ones.
Dr. Matthew Hellmann of Memorial Sloan Kettering Cancer Center discusses new FDA approvals, clinical trials, and potential treatments for patients with small cell lung cancer.
Dr. Rony Dahan of Weizmann Institute of Science (Israel) discusses the latest advances in targeted antibodies for the effective treatment of many forms of cancer.
Two cancer patients—Stephen Estrada and Mary Elizabeth Williams—discuss how they regained control after their cancer diagnosis
Dr. Gavin Dunn of Washington University in St. Louis discusses how cancer vaccines are capable of educating patients’ immune systems and have the potential to improve the immune system’s ability to target and eliminate cancer.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
CRI’s focus on immunology research—while primarily aimed at curing cancer—also has contributed to advances in the treatment and prevention of infectious diseases.
We spoke with the five inaugural CRI Lloyd J. Old STARs to learn more about their work and what they hope to accomplish during the next five years.